Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
PPMI News
Donate Now
Parkinson's Research: PPMI Clinical Study

PPMI News

The Parkinson's Progression Markers Initiative is our landmark study launched in 2010 to deepen knowledge of Parkinson's and to better understand its onset and progression to speed the development of new treatments. Learn the latest news from the study here.

  • Default content image

    New Study Protocol incorporating following subjects with SWEDD now posted

    An updated protocol has been posted to the PPMI site. This is the 3rd amendment to the protocol and incorporates a third cohort into the PPMI study.
    Learn more
  • Default content image

    Clinical Data and Biospecimens available for over 200 subjects

    We are pleased to announce that PPMI has now enrolled over 200 subjects.
    Learn more
  • Default content image

    PPMI Diffusion Tensor Imaging Sub-study One of the Largest Ever in Parkinson's disease

    In addition to collecting structural MRI data, seven PPMI sites will also be performing diffusion tensor imaging (DTI), an MRI technique that analyzes the movement of water molecules in brain tissue. 
    Learn more
  • Default content image

    The Department of Cures: It's us

    While there's no doubt that receiving a diagnosis of serious illness remains a life-changer, today, many patients can look forward to a much brighter prognosis, thanks to new and better…
    Learn more
  • Default content image

    Paracelsus-Elena Klinik featured in Hessische Allgemeine

    Kassel is once again a center for international research: The Paracelsus-Elena-Clinic is taking part in a study for the early detection and the progression of Parkinson’s disease.
    Learn more
  • Default content image

    Qualification study in healthy volunteers prompts investigators to explore fluctuation of markers in Parkinson's disease subjects

    As part of the planning phase of PPMI last fall, MJFF sponsored a qualification study to assess the test/re-test reliability of specific biomarker assays.
    Learn more
  • Default content image

    Repositioning RFA, A Potential PD Vaccine and PPMI Update

    In the fall 2011 issue of our newsletter, Accelerating the Cure, Nate Herpich, MJFF's associate director of research communications, provided updates on some of our funding.
    Learn more
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year